Azoospermia due to radiation
ICD-10 N46.024 is a billable code used to indicate a diagnosis of azoospermia due to radiation.
Azoospermia due to radiation refers to the absence of sperm in the ejaculate as a result of exposure to ionizing radiation. This condition can occur in males who have undergone radiation therapy for cancer treatment, particularly in the pelvic region, which can adversely affect testicular function. The radiation can damage the seminiferous tubules, where sperm production occurs, leading to impaired spermatogenesis. Patients may present with symptoms of infertility, and the diagnosis is typically confirmed through semen analysis. Management may involve assisted reproductive technologies, such as sperm retrieval techniques, and counseling regarding fertility preservation prior to radiation exposure. The impact of radiation on male fertility is significant, and understanding the underlying mechanisms is crucial for effective treatment and management of affected individuals.
Detailed history of radiation exposure, semen analysis results, and treatment plans.
Patients presenting with infertility post-radiation therapy.
Consideration of sperm banking prior to radiation therapy.
Records of cancer diagnosis, treatment protocols, and potential reproductive health discussions.
Patients undergoing treatment for pelvic cancers who require fertility preservation counseling.
Coordination with urology for fertility assessments post-treatment.
Used to confirm diagnosis of azoospermia.
Document the results of the semen analysis and any prior treatments.
Urologists should ensure comprehensive fertility evaluations.
The primary cause is damage to the testicular tissue from radiation exposure, which disrupts normal sperm production.
